Plasma calprotectin and its association with cardiovascular disease manifestations, obesity and the metabolic syndrome in type 2 diabetes mellitus patients
about
Revisiting the adipocyte: a model for integration of cytokine signaling in the regulation of energy metabolismNutritional Immunity: S100 Proteins at the Host-Pathogen Interface.Role of Calprotectin as a Modulator of the IL27-Mediated Proinflammatory Effect on Endothelial Cells.Oleanolic Acid Attenuates Insulin Resistance via NF-κB to Regulate the IRS1-GLUT4 Pathway in HepG2 CellsCalprotectin in serum and zonulin in serum and feces are elevated after introduction of a diet with lower carbohydrate content and higher fiber, fat and protein contents.Total Flavonoids Extracted from Oxytropis falcata Bunge Improve Insulin Resistance through Regulation on the IKKβ/NF-κB Inflammatory Pathway.Ischemic colitis of the colon in streptozotocin-induced diabetic rats.Is calprotectin a novel biomarker of neuroinflammation in diabetic periferal neuropathy?Association of calprotectin with leukocyte chemotactic and inflammatory mediators following acute aerobic exercise.Elevated serum tartrate-resistant acid phosphatase isoform 5a levels in metabolic syndrome.Reduction of calprotectin and phosphate during testosterone therapy in aging men: a randomized controlled trial.Multiple gut-liver axis abnormalities in children with obesity with and without hepatic involvement.Two meals with different carbohydrate, fat and protein contents render equivalent postprandial plasma levels of calprotectin, cortisol, triglycerides and zonulin.Association of circulating calprotectin with lipid profile in axial spondyloarthritis
P2860
Q28085224-2550393A-1A72-4C73-87F5-75ACE4E7B799Q35905318-97103F58-54A6-4BF2-9F5A-6CBF30282159Q36333169-DEF24961-3296-40A9-A0EC-DA9C1B151F3FQ36457236-921B4982-D777-43CA-8C40-497EE76A5BFFQ37732016-490B6619-E0B0-49EF-8BAC-D5F401C70A1AQ37742657-3A717FF1-8929-45DC-A959-16EA5B4AE817Q38646383-4ACE72BA-6DF7-42E0-9C59-A58211033CF1Q40878625-C2E5F9D3-C141-47F5-A805-A11C23F75A52Q45023594-F2DF9769-AB56-48DB-86B9-55D5718CEBEAQ47140169-374A0C06-7118-4C11-B9E5-E4A70EDA7320Q51246104-67EE41E3-96A6-4189-9C1B-6E8ABBBA96B0Q51500710-8026510A-D71D-476C-91F1-73C22DC860BDQ51675582-5CA6F7BF-CD44-40DC-A484-DF42C9CA499EQ58743766-68CB392B-359F-4991-A922-7AA7644F6C2A
P2860
Plasma calprotectin and its association with cardiovascular disease manifestations, obesity and the metabolic syndrome in type 2 diabetes mellitus patients
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Plasma calprotectin and its as ...... e 2 diabetes mellitus patients
@ast
Plasma calprotectin and its as ...... e 2 diabetes mellitus patients
@en
Plasma calprotectin and its as ...... e 2 diabetes mellitus patients
@nl
type
label
Plasma calprotectin and its as ...... e 2 diabetes mellitus patients
@ast
Plasma calprotectin and its as ...... e 2 diabetes mellitus patients
@en
Plasma calprotectin and its as ...... e 2 diabetes mellitus patients
@nl
prefLabel
Plasma calprotectin and its as ...... e 2 diabetes mellitus patients
@ast
Plasma calprotectin and its as ...... e 2 diabetes mellitus patients
@en
Plasma calprotectin and its as ...... e 2 diabetes mellitus patients
@nl
P2093
P2860
P50
P921
P356
P1476
Plasma calprotectin and its as ...... e 2 diabetes mellitus patients
@en
P2093
Lise Pedersen
Mikael Kjær Poulsen
P2860
P2888
P356
10.1186/1471-2261-14-196
P577
2014-12-19T00:00:00Z
P5875
P6179
1021871803